Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion de Jong

Showing results (31-40 of 193) with videos related to

Pageof 20
Sort By:
Cancer Biotherapy & Radiopharmaceuticals|February 5, 2016
Improving the In Vivo Profile of Minigastrin Radiotracers: A Comparative Study Involving the Neutral Endopeptidase Inhibitor PhosphoramidonAikaterini Kaloudi, Berthold A Nock, Emmanouil Lymperis, et al.
Nuclear Medicine and Biology|June 5, 2016
(99m)Tc-labeled gastrins of varying peptide chain length: Distinct impact of NEP/ACE-inhibition on stability and tumor uptake in miceAikaterini Kaloudi, Berthold A Nock, Emmanouil Lymperis, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 17, 2002
Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginineEdgar J Rolleman, Roelf Valkema, Marion de Jong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 18, 2005
Combination radionuclide therapy using 177Lu- and 90Y-labeled somatostatin analogsMarion de Jong, Wout A P Breeman, Roelf Valkema, et al.
Accounts of Chemical Research|May 19, 2009
Tumor imaging and therapy using radiolabeled somatostatin analoguesMarion de Jong, Wout A P Breeman, Dik J Kwekkeboom, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 8, 2003
Peptide receptor radionuclide therapy in vitro using [111In-DTPA0]octreotideAstrid Capello, Eric P Krenning, Wout A P Breeman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 10, 2004
Uptake of [111In-DTPA0]octreotide in the rat kidney is inhibited by colchicine and not by fructoseEdgar J Rolleman, Eric P Krenning, Arthur Van Gameren, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 7, 2005
Oral versus intravenous administration of lysine: equal effectiveness in reduction of renal uptake of [111In-DTPA]octreotideSuzanne M Verwijnen, Eric P Krenning, Roelf Valkema, et al.
Pharmaceutics|June 13, 2020
Key-Protease Inhibition Regimens Promote Tumor Targeting of Neurotensin RadioligandsPanagiotis Kanellopoulos, Aikaterini Kaloudi, Marion de Jong, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 13, 2015
Biomarkers in preclinical cancer imagingMonique R Bernsen, Klazina Kooiman, Marcel Segbers, et al.
Pageof 20

Showing results (31-40 of 193) with videos related to

Sort By:
Pageof 20
Cancer Biotherapy & Radiopharmaceuticals|February 5, 2016
Improving the In Vivo Profile of Minigastrin Radiotracers: A Comparative Study Involving the Neutral Endopeptidase Inhibitor PhosphoramidonAikaterini Kaloudi, Berthold A Nock, Emmanouil Lymperis, et al.
Nuclear Medicine and Biology|June 5, 2016
(99m)Tc-labeled gastrins of varying peptide chain length: Distinct impact of NEP/ACE-inhibition on stability and tumor uptake in miceAikaterini Kaloudi, Berthold A Nock, Emmanouil Lymperis, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 17, 2002
Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginineEdgar J Rolleman, Roelf Valkema, Marion de Jong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 18, 2005
Combination radionuclide therapy using 177Lu- and 90Y-labeled somatostatin analogsMarion de Jong, Wout A P Breeman, Roelf Valkema, et al.
Accounts of Chemical Research|May 19, 2009
Tumor imaging and therapy using radiolabeled somatostatin analoguesMarion de Jong, Wout A P Breeman, Dik J Kwekkeboom, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 8, 2003
Peptide receptor radionuclide therapy in vitro using [111In-DTPA0]octreotideAstrid Capello, Eric P Krenning, Wout A P Breeman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 10, 2004
Uptake of [111In-DTPA0]octreotide in the rat kidney is inhibited by colchicine and not by fructoseEdgar J Rolleman, Eric P Krenning, Arthur Van Gameren, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 7, 2005
Oral versus intravenous administration of lysine: equal effectiveness in reduction of renal uptake of [111In-DTPA]octreotideSuzanne M Verwijnen, Eric P Krenning, Roelf Valkema, et al.
Pharmaceutics|June 13, 2020
Key-Protease Inhibition Regimens Promote Tumor Targeting of Neurotensin RadioligandsPanagiotis Kanellopoulos, Aikaterini Kaloudi, Marion de Jong, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 13, 2015
Biomarkers in preclinical cancer imagingMonique R Bernsen, Klazina Kooiman, Marcel Segbers, et al.
Pageof 20